Prostate Cancer Pathology Not Worse With Delayed Surgery
FRIDAY, Dec. 11, 2020 -- Among men with clinically localized high-risk prostate adenocarcinoma undergoing radical prostatectomy, surgical delay time (SDT) is not associated with a higher risk for adverse pathological features or with worse overall survival, according to a study published online Dec. 8 in JAMA Network Open.
Leilei Xia, M.D., from the University of Pennsylvania Perelman School of Medicine in Philadelphia, and colleagues examined the association of SDT of radical prostatectomy with final pathological and survival outcomes among patients with clinically localized high-risk prostate adenocarcinoma diagnosed between 2006 and 2016 who underwent radical prostatectomy. Data were included for 32,184 patients.
The researchers found that having longer SDT compared with an SDT of 31 to 60 days was not associated with increased risks for any adverse pathological outcomes, pT3 to T4 disease, pN-positive disease, positive surgical margin, or adverse pathological score greater than or equal to 2. There was also no association for longer SDT with worse overall survival.
"These findings suggest that prostate cancer surgery can be safely delayed up to six months and should be considered as low priority compared with other emergent and cancer surgeries when health care resources need to be prioritized during special times, such as the coronavirus disease 2019 pandemic," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
THURSDAY, Jan. 21, 2021 -- For men with newly diagnosed prostate cancer on active surveillance, adherence to the Mediterranean diet (MedD) is associated with a lower risk for...
TUESDAY, Jan. 19, 2021 -- Routine use of prophylactic postoperative antibiotics does not improve outcomes following endoscopic sinus surgery (ESS) for chronic rhinosinusitis,...
FRIDAY, Jan. 15, 2021 -- Most patients undergoing mastectomy alone, known as "going flat," are satisfied with their surgical outcome, according to a study published online Jan. 3...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.